CSIMarket


Axonics Inc   (AXNX)
Other Ticker:  
 


 

Axonics Inc

AXNX's Financial Statements and Analysis



Axonics Inc reported in the forth quarter of 2023 net earnings per share of $0.13 an increase by 888.37 % year on year from $0.01 and an improvement of 59.72 % from $0.08 realized in III. Quarter (Sep 30 2023).


forth quarter of 2023
Earnings Per Share Revenues
$ 0.13 $  110 Mill
$+0.12     +888.37 % $+24M     +27.92 %



Axonics Inc 's Revenue rose by 27.92 % in forth quarter of 2023 (Dec 31 2023) year on year, to $110 million and advanced by 19.33 % sequentially.


Axonics Inc is

More on AXNX's Income Statement



Axonics Inc 's net income of $6.574 million in the forth quarter of 2023 increased by 888.57 % from net earnings of $0.665 million achieved in IV. Quarter a year ago.

Sequentially net earnings grew by 67.36 % from net income of $3.928 million realized in previous quarter.

More on AXNX's Growth

Axonics Inc Inventories
Inventories grew by 43.35 % to $80 million from IV. Quarter a year ago, sequentially inventories rose by 6.72 %. In Dec 31 2023 company's net cash and cash equivalents decreased by $-30 million, capital expenditures fell by -0.335290.15%, to $-1 millions compare to same quarter a year ago

More on AXNX's Cash flow Statement


Axonics Inc does not pay out common stock dividend.

In trailing twelve-month period Axonics Inc payed $ -0.04 cash per share, on a free-cash flow basis .

Book value grew by 3.08 % sequentially to $12.57 per share.
Tangible Book value grew to $ 9.00 per share from $ 8.69.

Company issued 0.65 million shares or 1.29 % in Dec 31 2023.


More on AXNX's Dividends

 Market Capitalization (Millions) 3,440
 Shares Outstanding (Millions) 51
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 366
 Net Income (TTM) (Millions $) -6
 Cash Flow (TTM) (Millions $) -121
 Capital Exp. (TTM) (Millions $) -4
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 325




Axonics Inc does not pay out common stock dividend.

In trailing twelve-month period Axonics Inc had negative $ -0.04 cash flow per share, on a free-cash flow basis .

Book value grew by 3.08 % sequentially to $12.57 per share.
Tangible Book value grew to $ 9.00 per share from $ 8.69.

Company issued 0.65 million shares or 1.29 % in Dec 31 2023.


More on AXNX's Balance Sheets

 Market Capitalization (Millions) 3,440
 Shares Outstanding (Millions) 51
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 366
 Net Income (TTM) (Millions $) -6
 Cash Flow (TTM) (Millions $) -121
 Capital Exp. (TTM) (Millions $) -4
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 325
   


  News about Axonics Inc Earnings

2 Axonics Inc sets new standards in profitability and revenue growth in the Medical Equipment & Supplies sector



Axonics Inc, a prominent player in the Medical Equipment and Supplies sector, has recently reported remarkable financial results for the fiscal year ending on December 31, 2023. With soaring net profit per share and substantial revenue growth, the company has undoubtedly outperformed its sector peers. Moreover, Axonics Inc's improving profit margins, increasing inventories, and rising accounts receivable highlight a positive outlook for the company's future.
Skyrocketing Profitability and Revenue Growth:
In the fourth quarter of 2023, Axonics Inc witnessed an astounding 888.37% year-on-year increase in net profit per share, reaching $0.13 per share. This exceptional growth reflects the comp...

Axonics Inc. Achieves Epic Results in Q3 of 2023, Reveals Impressive Figures



Axonics Inc, a medical equipment and supplies company, has reported impressive financial results for the third quarter of 2023. The company has achieved significant growth in revenue, turned a profit, and witnessed an increase in both inventories and accounts receivable. This article aims to highlight the key facts from Axonics Inc's financial results and provide an analysis of its performance in the context of the medical equipment and supplies sector.
Financial Performance Overview:
In the third quarter of 2023, Axonics Inc exhibited a remarkable turnaround by reporting earnings per share (EPS) of $0.08. This marks a substantial improvement compared to the EPS of -$0.34 reported in the sa...

Strong Q2 2023 Earnings Report Shows Axonics Inc. Overcoming Diminishing Returns Despite Industry Challenges

Axonics Inc Reports Strong Second Quarter Earnings Amid Industry Challenges
In the face of declining orders and revenue across the Medical Equipment and Supplies industry, Axonics Inc (AXNX) showcased an impressive performance in the second quarter of 2023. The company reported a significant reduction in loss per share, while also witnessing improved income per share compared to the previous reporting period.
During the second quarter of 2023 earnings season, Axonics Inc reported a loss of $0.15 per share, a significant improvement from the loss of $0.47 per share recorded a year earlier. Moreover, income per share also saw positive growth, improving from a loss of $0.19 per share in the prior report...

The company announced a remarkable achievement, all along the fiscal period ending March 31 2023

Axonics Inc: A Growing Medical Equipment and Supplies Company
Axonics Inc is a medical equipment and supplies company that has been on the rise in recent years. Founded in 2013, the company is focused on designing, developing, and commercializing implantable sacral neuromodulation devices for patients with urinary and bowel dysfunction.
Despite facing some setbacks in the first quarter of 2023, Axonics Inc has shown remarkable growth in its revenue over the past year. In the fiscal period ending March 31, 2023, the company's revenue surged by 45.911% to $70.65 million from the comparable reporting season a year before. However, the company still reported a net loss of $-0.19 per share in the same per...


Date modified: 2024-02-29T16:11:06+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com